Merck & Co. Inc. (MRK) - Pharmaceutical Revenue (I:MCIMVWPP)
Level Chart
Basic Info
Merck & Co. Inc. (MRK) - Pharmaceutical Revenue is at a current level of 14.01B, up from 13.14B last quarter and up from 12.72B one year ago. This is a change of 6.58% from last quarter and 10.10% from one year ago. |
Pharmaceutical Revenue refers to the total revenue generated by Merck from the sale of its pharmaceutical products. This includes revenue from prescription drugs, over-the-counter medications, vaccines, and other pharmaceutical products developed and marketed by the company. |
Report | FinChat.io |
Category | Segments & KPIs |
Region | United States |
Source | FinChat.io |
Data provided via FinChat.io |
Stats
Last Value | 14.01B |
Latest Period | Mar 2024 |
Last Updated | Apr 30 2024, 23:23 EDT |
Next Release | Jul 31 2024, 23:00 EDT (E) |
Average Growth Rate | 8.56% |
Value from Last Quarter | 13.14B |
Change from Last Quarter | 6.58% |
Value from 1 Year Ago | 12.72B |
Change from 1 Year Ago | 10.10% |
Frequency | Quarterly |
Unit | USD |
Adjustment | N/A |
Historical Data
Date | Value |
---|---|
March 31, 2024 | 14.01B |
December 31, 2023 | 13.14B |
September 30, 2023 | 14.26B |
June 30, 2023 | 13.46B |
March 31, 2023 | 12.72B |
December 31, 2022 | 12.18B |
September 30, 2022 | 12.96B |
June 30, 2022 | 12.76B |
March 31, 2022 | 14.11B |
Date | Value |
---|---|
December 31, 2021 | 12.04B |
September 30, 2021 | 11.50B |
June 30, 2021 | 9.98B |
March 31, 2021 | 9.238B |
December 31, 2020 | 9.813B |
September 30, 2020 | 9.714B |
June 30, 2020 | 8.178B |
March 31, 2020 | 8.905B |
December 31, 2019 | 10.53B |
Basic Info
Merck & Co. Inc. (MRK) - Pharmaceutical Revenue is at a current level of 14.01B, up from 13.14B last quarter and up from 12.72B one year ago. This is a change of 6.58% from last quarter and 10.10% from one year ago. |
Pharmaceutical Revenue refers to the total revenue generated by Merck from the sale of its pharmaceutical products. This includes revenue from prescription drugs, over-the-counter medications, vaccines, and other pharmaceutical products developed and marketed by the company. |
Report | FinChat.io |
Category | Segments & KPIs |
Region | United States |
Source | FinChat.io |
Data provided via FinChat.io |
Stats
Last Value | 14.01B |
Latest Period | Mar 2024 |
Last Updated | Apr 30 2024, 23:23 EDT |
Next Release | Jul 31 2024, 23:00 EDT (E) |
Average Growth Rate | 8.56% |
Value from Last Quarter | 13.14B |
Change from Last Quarter | 6.58% |
Value from 1 Year Ago | 12.72B |
Change from 1 Year Ago | 10.10% |
Frequency | Quarterly |
Unit | USD |
Adjustment | N/A |
Related Securities
Related Indicators
Merck & Co. Inc. (MRK) - Animal Health Revenue | 5.625B USD |
Merck & Co. Inc. (MRK) - Animal Health Revenue | 1.278B USD |
Merck & Co. Inc. (MRK) - Other Revenue | 907.00M USD |
Merck & Co. Inc. (MRK) - Other Revenue | 211.00M USD |
Merck & Co. Inc. (MRK) - Pharmaceutical Revenue | 53.58B USD |